Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedOn 2026-09-17 the study record was updated to revision v3.7.0, introducing Business Reasons and new status fields (Study Status and Recruitment Status). The previous Completed entry from revision v3.6.6 was removed on 2026-06-26.SummaryDifference0.2%

- Check36 days agoChange DetectedThe version history now shows the current release as Revision: v3.6.6, replacing the previous Revision: v3.6.5 in the history.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a software version update rather than changes to study data or page content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new build/version of the study history page.SummaryDifference0.0%

- Check86 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the study history, replacing the previous 'Revision: v3.6.2'. This reflects an updated platform release recorded in the version history.SummaryDifference0.0%

- Check100 days agoChange DetectedA new history entry was added for 2026-06-26 indicating a Study Status update with version 142 and Revision: v3.6.2, and an earlier 2026-02-20 entry as well as Revision: v3.6.0 were removed.SummaryDifference0.1%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.